Bangladesh approves late-stage trial of China’s Sinovac COVID-19 vaccine candidate

DHAKA (Reuters) – Bangladesh has approved a late-stage trial of a potential COVID-19 vaccine developed by China’s Sinovac Biotech Ltd in the hope of being a priority recipient for the jab, the health …
( read original story …)